+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peptic Ulcer Treatment Drugs Market - Global Forecast 2026-2032- Product Image
Peptic Ulcer Treatment Drugs Market - Global Forecast 2026-2032- Product Image
Sale

Peptic Ulcer Treatment Drugs Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129674
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Peptic Ulcer Treatment Drugs Market is projected to reach USD 3.87 Billion in 2026. It is expected to continue growing at a CAGR of 10.21%, reaching USD 6.91 Billion by 2032.

Peptic Ulcer Treatment Drugs: Executive Overview

Peptic ulcer treatment drugs address mucosal damage in the stomach or duodenum, with therapy selected according to ulcer cause, severity, bleeding risk, recurrence risk, and patient comorbidities. Standard care commonly combines acid suppression, eradication therapy when Helicobacter pylori is confirmed or suspected, and discontinuation or mitigation of ulcerogenic medicines where clinically appropriate. Treatment decisions increasingly emphasize diagnostic accuracy, antimicrobial stewardship, adherence, drug interactions, and prevention of recurrence.

Treatment Is Shifting Toward Cause-Specific, Safer Care

The treatment landscape is moving from symptom control alone toward cause-specific management. Testing and treatment for H. pylori, careful review of nonsteroidal anti-inflammatory drug exposure, risk stratification for gastrointestinal bleeding, and follow-up for complicated or recurrent disease are central to this shift. Proton-pump inhibitors remain important acid-suppressive therapies, while histamine-2 receptor antagonists, protective agents, and combination regimens may be used according to clinical circumstances and local guidance. Concerns about antimicrobial resistance, inappropriate long-term acid suppression, polypharmacy, and medicine access are encouraging more individualized prescribing.

Artificial Intelligence Strengthens Diagnosis, Monitoring, and Stewardship

Artificial intelligence can support peptic ulcer care by helping interpret endoscopic images, identify bleeding features, prioritize high-risk cases, and detect patterns associated with recurrence or treatment failure. It may also assist medication reconciliation, adherence monitoring, interaction screening, and selection of diagnostic pathways. These applications require clinically representative validation, transparent performance measures, protection of patient data, and human oversight. AI should augment-not replace-endoscopists, pharmacists, and physicians, particularly when malignancy, perforation, obstruction, or acute bleeding is possible.

Regional Priorities Reflect Unequal Disease Burden and Access

In North America and Europe, priorities include reducing avoidable ulcer complications, managing long-term acid-suppression exposure, and addressing antimicrobial resistance. Latin America faces the combined importance of H. pylori control, medicine affordability, and uneven access to testing and endoscopy. The Middle East requires approaches that account for varied healthcare capacity, referral pathways, and prescribing practices, while Africa continues to benefit from stronger diagnostic access, essential-medicine availability, and emergency management capability. Asia-Pacific presents substantial diversity: advanced systems can emphasize precision diagnosis and surveillance, whereas lower-resource settings may prioritize reliable testing, treatment completion, and early referral.

Economic and Security Groupings Reveal Shared Policy Challenges

ASEAN members share priorities around affordable diagnostics, treatment continuity, and cross-border variation in clinical capacity. BRICS economies face differing burdens of antimicrobial resistance, healthcare access, and public-sector procurement needs. The European Union can benefit from coordinated stewardship, evidence standards, and cross-border health planning. G7 systems generally have stronger specialist infrastructure but must address aging populations, polypharmacy, and inappropriate prolonged therapy. GCC countries often combine advanced tertiary care with the need to harmonize prevention and referral practices. NATO members may also consider continuity of gastrointestinal care and essential medicines during emergencies that disrupt supply chains or healthcare delivery.

Country Contexts Require Differentiated Treatment Strategies

Australia and Canada can focus on stewardship, equitable rural access, and management of medication-related ulcer risk. Brazil, Mexico, India, China, Russia, and South Korea require approaches that reflect large or diverse populations, varying access to endoscopy, and local resistance patterns. France, Germany, Italy, Spain, and the United Kingdom can emphasize guideline-concordant prescribing, follow-up of complicated disease, and reduction of unnecessary long-term therapy. Japan’s mature healthcare infrastructure supports attention to diagnostic precision, age-related risk, and medication safety. Across the United States, priorities include care coordination, opioid- and anti-inflammatory-related comorbidity management, access disparities, and prevention of avoidable hospitalizations.

Industry Leaders Should Prioritize Evidence, Access, and Responsible Innovation

Leaders should align product development and medical education with guideline-defined clinical needs, including effective H. pylori eradication, resistance-aware therapy, safe acid suppression, and treatment of high-risk bleeding. They should support diagnostic stewardship, adherence programs, pharmacist involvement, and transparent safety communication rather than encouraging indiscriminate prolonged use. Regional strategies should account for affordability, essential-medicine supply continuity, local resistance data, and healthcare-worker training. AI investments should begin with validated, interoperable tools and clear accountability. Partnerships with clinicians, laboratories, hospitals, and public-health agencies can help translate evidence into consistent care.

Methodology Grounded in Clinical Evidence and Health-System Context

This executive summary uses the supplied market definition-peptic ulcer treatment drugs-and synthesizes established clinical principles, treatment pathways, public-health considerations, and health-system differences. The analysis distinguishes treatment of underlying causes from symptom relief and considers diagnostic access, antimicrobial resistance, medication safety, adherence, and complications. Regional, group, and country observations are qualitative and intended to identify strategic priorities; they do not constitute market estimates, forecasts, market shares, or rankings. Clinical decisions should follow current local guidelines and patient-specific assessment.

The Strategic Imperative Is Better Targeted Ulcer Care

Peptic ulcer treatment is becoming more integrated, cause-specific, and safety conscious. The strongest opportunities for better outcomes lie in reliable H. pylori detection and eradication, prudent use of acid-suppressive medicines, resistance-aware prescribing, early recognition of complications, and equitable access to diagnostics and follow-up. Industry leaders that combine clinically credible innovation with stewardship, affordability, and responsible digital tools will be better positioned to support durable improvements in patient care across diverse health systems.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Peptic Ulcer Treatment Drugs Market, by Product Type
7.1. Introduction
7.2. Over The Counter
7.3. Prescription
8. Peptic Ulcer Treatment Drugs Market, by Drug Class
8.1. Introduction
8.2. Antibiotics
8.2.1. Amoxicillin
8.2.2. Clarithromycin
8.2.3. Metronidazole
8.3. H2 Receptor Antagonists
8.3.1. Cimetidine
8.3.2. Famotidine
8.3.3. Nizatidine
8.3.4. Ranitidine
8.4. Mucosal Protectants
8.5. Proton Pump Inhibitors
8.5.1. Esomeprazole
8.5.2. Lansoprazole
8.5.3. Omeprazole
8.5.4. Pantoprazole
8.5.5. Rabeprazole
9. Peptic Ulcer Treatment Drugs Market, by Dosage Form
9.1. Introduction
9.2. Capsules
9.3. Powders
9.4. Suspensions
9.5. Tablets
10. Peptic Ulcer Treatment Drugs Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care
10.4. Hospitals
11. Peptic Ulcer Treatment Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Peptic Ulcer Treatment Drugs Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Peptic Ulcer Treatment Drugs Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Peptic Ulcer Treatment Drugs Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AbbVie Inc.
16.2. Alkem Laboratories Ltd.
16.3. Allergan PLC
16.4. AstraZeneca PLC
16.5. Aurobindo Pharma Ltd.
16.6. Bayer AG
16.7. Boehringer Ingelheim International GmbH
16.8. Bristol-Myers Squibb Company
16.9. Cipla Limited
16.10. Dr. Reddy’s Laboratories Ltd.
16.11. Eli Lilly and Company
16.12. GlaxoSmithKline plc
16.13. Intas Pharmaceuticals Ltd.
16.14. Johnson & Johnson
16.15. Lupin Limited
16.16. Merck & Co., Inc.
16.17. Mylan N.V.
16.18. Novartis AG
16.19. Pfizer Inc.
16.20. Sandoz International GmbH
16.21. Sanofi S.A.
16.22. Sun Pharmaceutical Industries Ltd.
16.23. Takeda Pharmaceutical Company Limited
16.24. Teva Pharmaceutical Industries Ltd.
16.25. Zydus Lifesciences Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Peptic Ulcer Treatment Drugs Market, Years Considered for the Study
FIGURE 2. Global Peptic Ulcer Treatment Drugs Market, Research Design
FIGURE 3. Global Peptic Ulcer Treatment Drugs Market, Research Framework
FIGURE 4. Global Peptic Ulcer Treatment Drugs Market, Data Triangulation
FIGURE 5. Global Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2025 vs 2032 (%)
FIGURE 9. Global Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 11. Global Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Peptic Ulcer Treatment Drugs Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Peptic Ulcer Treatment Drugs Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Peptic Ulcer Treatment Drugs Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Peptic Ulcer Treatment Drugs Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Peptic Ulcer Treatment Drugs Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Peptic Ulcer Treatment Drugs Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Peptic Ulcer Treatment Drugs Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Peptic Ulcer Treatment Drugs Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Peptic Ulcer Treatment Drugs Market Segmentation & Coverage
TABLE 2. Global Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 3. Global Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Over The Counter Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Over The Counter Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Over The Counter Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Prescription Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Prescription Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Prescription Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 11. Global Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Antibiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Amoxicillin Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Amoxicillin Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Amoxicillin Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Clarithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Clarithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Clarithromycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Metronidazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Metronidazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Metronidazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global H2 Receptor Antagonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global H2 Receptor Antagonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global H2 Receptor Antagonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Cimetidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Cimetidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Cimetidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Famotidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Famotidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Famotidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Nizatidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Nizatidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Nizatidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Ranitidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Ranitidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Ranitidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Mucosal Protectants Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Mucosal Protectants Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Mucosal Protectants Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Proton Pump Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Proton Pump Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Proton Pump Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Esomeprazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Esomeprazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Esomeprazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Lansoprazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Lansoprazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Lansoprazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Omeprazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Omeprazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Omeprazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Pantoprazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Pantoprazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Pantoprazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Rabeprazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Rabeprazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Rabeprazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 60. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Powders Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Powders Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Powders Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Suspensions Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Suspensions Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Suspensions Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Peptic Ulcer Treatment Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Peptic Ulcer Treatment Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 102. North America Peptic Ulcer Treatment Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. North America Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. North America Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 105. North America Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 106. North America Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 107. North America Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 108. North America Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 109. North America Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. North America Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. Latin America Peptic Ulcer Treatment Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Latin America Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Latin America Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 114. Latin America Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 115. Latin America Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 116. Latin America Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 117. Latin America Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 118. Latin America Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Latin America Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. Europe Peptic Ulcer Treatment Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Europe Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 122. Europe Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 123. Europe Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 124. Europe Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 125. Europe Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 126. Europe Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 127. Europe Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Europe Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. Middle East Peptic Ulcer Treatment Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Middle East Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 131. Middle East Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 132. Middle East Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 133. Middle East Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 134. Middle East Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 135. Middle East Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 136. Middle East Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. Middle East Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. Africa Peptic Ulcer Treatment Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Africa Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. Africa Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 141. Africa Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 142. Africa Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 143. Africa Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 144. Africa Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 145. Africa Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Africa Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. Global Peptic Ulcer Treatment Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. ASEAN Peptic Ulcer Treatment Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. ASEAN Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 150. ASEAN Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 151. ASEAN Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 152. ASEAN Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 153. ASEAN Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 154. ASEAN Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 155. ASEAN Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. ASEAN Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. GCC Peptic Ulcer Treatment Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. GCC Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 159. GCC Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 160. GCC Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 161. GCC Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 162. GCC Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 163. GCC Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 164. GCC Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. GCC Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. European Union Peptic Ulcer Treatment Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. European Union Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. European Union Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 169. European Union Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 170. European Union Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 171. European Union Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 172. European Union Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 173. European Union Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. European Union Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. BRICS Peptic Ulcer Treatment Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. BRICS Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. BRICS Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 178. BRICS Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 179. BRICS Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 180. BRICS Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 181. BRICS Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 182. BRICS Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. BRICS Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. G7 Peptic Ulcer Treatment Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. G7 Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. G7 Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 187. G7 Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 188. G7 Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 189. G7 Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 190. G7 Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 191. G7 Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. G7 Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. NATO Peptic Ulcer Treatment Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. NATO Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 195. NATO Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 196. NATO Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 197. NATO Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 198. NATO Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 199. NATO Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 200. NATO Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. NATO Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Global Peptic Ulcer Treatment Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 203. United States Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 204. United States Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. United States Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 206. United States Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 207. United States Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 208. United States Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 209. United States Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 210. United States Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. United States Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. Canada Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 213. Canada Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. Canada Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 215. Canada Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 216. Canada Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 217. Canada Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 218. Canada Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 219. Canada Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Canada Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. Mexico Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 222. Mexico Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. Mexico Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 224. Mexico Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 225. Mexico Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 226. Mexico Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 227. Mexico Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 228. Mexico Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Mexico Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. Brazil Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 231. Brazil Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Brazil Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 233. Brazil Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 234. Brazil Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 235. Brazil Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 236. Brazil Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 237. Brazil Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Brazil Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. United Kingdom Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 240. United Kingdom Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. United Kingdom Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 242. United Kingdom Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 243. United Kingdom Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 244. United Kingdom Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 245. United Kingdom Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 246. United Kingdom Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. United Kingdom Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 248. Germany Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 249. Germany Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 250. Germany Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 251. Germany Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 252. Germany Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 253. Germany Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 254. Germany Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 255. Germany Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Germany Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 257. France Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 258. France Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. France Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 260. France Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 261. France Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 262. France Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 263. France Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 264. France Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. France Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 266. Russia Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 267. Russia Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 268. Russia Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 269. Russia Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 270. Russia Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 271. Russia Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 272. Russia Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 273. Russia Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Russia Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. Italy Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 276. Italy Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. Italy Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 278. Italy Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 279. Italy Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 280. Italy Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 281. Italy Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 282. Italy Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Italy Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. Spain Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 285. Spain Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 286. Spain Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 287. Spain Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 288. Spain Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 289. Spain Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 290. Spain Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 291. Spain Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Spain Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 293. China Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 294. China Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 295. China Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 296. China Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 297. China Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 298. China Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 299. China Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 300. China Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. China Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 302. India Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 303. India Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 304. India Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 305. India Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 306. India Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 307. India Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 308. India Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 309. India Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. India Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 311. Japan Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 312. Japan Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 313. Japan Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 314. Japan Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 315. Japan Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 316. Japan Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 317. Japan Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 318. Japan Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. Japan Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 320. Australia Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 321. Australia Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 322. Australia Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 323. Australia Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 324. Australia Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 325. Australia Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 326. Australia Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 327. Australia Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 328. Australia Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 329. South Korea Peptic Ulcer Treatment Drugs Market Size, 2017-2032 (USD Million)
TABLE 330. South Korea Peptic Ulcer Treatment Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 331. South Korea Peptic Ulcer Treatment Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 332. South Korea Peptic Ulcer Treatment Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 333. South Korea Peptic Ulcer Treatment Drugs Market Size, by H2 Receptor Antagonists, 2017-2032 (USD Million)
TABLE 334. South Korea Peptic Ulcer Treatment Drugs Market Size, by Proton Pump Inhibitors, 2017-2032 (USD Million)
TABLE 335. South Korea Peptic Ulcer Treatment Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 336. South Korea Peptic Ulcer Treatment Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 337. South Korea Peptic Ulcer Treatment Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 338. Global Peptic Ulcer Treatment Drugs Market Share, by Key Player, 2025
TABLE 339. Global

Companies Mentioned

  • AbbVie Inc.
  • Alkem Laboratories Ltd.
  • Allergan PLC
  • AstraZeneca PLC
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol‑Myers Squibb Company
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Peptic Ulcer Drugs Market - Global Forecast 2026-2032 - Product Image

Peptic Ulcer Drugs Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Peptic Ulcer Drugs - Global Strategic Business Report - Product Image

Peptic Ulcer Drugs - Global Strategic Business Report

  • Report
  • 229 Pages
  • Global
From
Peptic Ulcer Drugs Market Size by Product Type, Ulcer Type, Distribution Channel, and Region 2026-2034 - Product Image

Peptic Ulcer Drugs Market Size by Product Type, Ulcer Type, Distribution Channel, and Region 2026-2034

  • Report
  • 149 Pages
  • Global
From
Peptic Ulcer Market Report 2026 - Product Image

Peptic Ulcer Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Peptic Ulcer Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Image

Peptic Ulcer Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.